AYLA · Categories · Form 4

AYLA - SEC Form 4 insider transactions

Ayala Pharmaceuticals Inc. (AYLA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for AYLA

• 1236d
  SEC Form 4: Amoon Growth Fund Limited Partnership returned 2,991,473 shares to the company

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1237d
  SEC Form 4: Maimon Yossi returned 69,872 shares to the company, closing all direct ownership in the company

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1237d
  SEC Form 4 filed by Spiegel Robert J.

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1237d
  SEC Form 4: Sidransky David returned 250 shares to the company

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1237d
  SEC Form 4: Mamluk Roni returned 265,345 shares to the company, closing all direct ownership in the company

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1237d
  SEC Form 4 filed by Bisker-Leib Vered

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1237d
  SEC Form 4 filed by Goldberg Murray A

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1237d
  SEC Form 4: Gordon Gary B. returned 58,520 shares to the company, closing all direct ownership in the company

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1459d
  SEC Form 4 filed by Sidransky David

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1459d
  SEC Form 4 filed by Goldberg Murray A

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1459d
  SEC Form 4 filed by Spiegel Robert J.

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1459d
  SEC Form 4 filed by Bisker-Leib Vered

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1489d
  SEC Form 4: Gordon Gary B. was granted 50,000 shares, increasing direct ownership by 587% to 58,520 units

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1489d
  SEC Form 4: Mamluk Roni was granted 120,000 shares, increasing direct ownership by 83% to 265,345 units

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1489d
  SEC Form 4: Maimon Yossi was granted 50,000 shares, increasing direct ownership by 252% to 69,872 units

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1620d
  SEC Form 4 filed by Gordon Gary B.

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1620d
  SEC Form 4 filed by Mamluk Roni

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1620d
  SEC Form 4 filed by Maimon Yossi

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1825d
  SEC Form 4 filed by Bisker-Leib Vered

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1825d
  SEC Form 4 filed by Spiegel Robert J.

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1825d
  SEC Form 4 filed by SIDRANSKY DAVID

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1825d
  SEC Form 4 filed by GOLDBERG MURRAY A

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1825d
  SEC Form 4 filed by Sone Todd

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1923d
  SEC Form 4: David Sidransky bought $3,700 worth of Common Stock (250 units at $14.80)

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1933d
  SEC Form 4: B. Gary Gordon exercised 3,000 units of Common Stock at a strike of $5.16 and sold $52,385 worth of Common Stock (3,000 units at $17.46)

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1935d
  SEC Form 4: Roni Mamluk sold $617,215 worth of Common Stock (33,126 units at $18.63), decreasing ownership by 19% to 145,345 units

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1968d
  SEC Form 4: Roni Mamluk sold $313,795 worth of Common Stock (20,872 units at $15.03), decreasing ownership by 10% to 178,471 units

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1968d
  SEC Form 4: B. Gary Gordon exercised 3,000 units of Common Stock at a strike of $5.16 and sold $45,084 worth of Common Stock (3,000 units at $15.03)

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)

Other AYLA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends